Missing KIR Ligand Effect in Autologous Stem Cell Transplantation
Author Information
Author(s): Stern M, Paulussen M, Rischewski J, Tichelli A, Gratwohl A
Primary Institution: Basel University Hospital
Hypothesis
Does the absence of KIR ligands affect disease-free survival and relapse rates in autologous stem cell transplantation?
Conclusion
The study found no significant effect of missing KIR ligands on disease-free survival or relapse rates in autologous HSCT recipients.
Supporting Evidence
- 67 autologous transplants were analyzed for solid tumors and lymphoma.
- Absence of KIR ligands had no effect on disease-free survival or disease relapse.
- Results were consistent even when focusing on T-cell-depleted transplants.
Takeaway
The researchers looked at whether not having certain proteins (KIR ligands) affected recovery after a specific type of cancer treatment, and they found it didn't make a difference.
Methodology
The study analyzed outcomes of 67 autologous transplants for solid tumors or lymphoma, grouping patients based on KIR ligand presence.
Limitations
The approach does not imply an inhibitory KIR/HLA mismatch, and the analysis was limited to commonly expressed KIR.
Participant Demographics
Patients included were those who underwent autologous HSCT between 1997 and 2006.
Statistical Information
P-Value
P=0.91 for DFS, P=0.23 for relapse
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website